Synovial inflammatory cells captured ¹³¹I-β₂-microglobulin in patients with dialysis related amyloidosis

References

• Gejyo F, Honma N, Arakawa M. Long-term complications of dialysis: pathogenetic factors with special reference to amyloidosis. Kidney Int 1993; 43(Suppl41)S78–S82
   Google Scholar
• Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kunitomo T, Kataoka H, Suzuki M, Hirasawa Y, Shirahama T, Cohen A S, Schmid K. A new form of amyloid protein associated with chronic hemodialysis was identified asβ2-microglobulin. Biochem Biophys Res Commun 1985; 129: 701–706
   PubMed Web of Science ®Google Scholar
• Sethi D, Gower P E. Synovial fluid beta 2-microglobulin levels in dialysis arthropathy (letter). N Eng J Med 1986; 315: 1419–1420
   PubMed Web of Science ®Google Scholar
• Kleinman K S, Coburn J W. Amyloid syndromes associated with hemodialysis. Kidney Int 1989; 35: 567–573
   PubMed Web of Science ®Google Scholar
• Koch K M. Dialysis-related amyloidosis. Kidney Int 1992; 41: 1416–1429
   PubMed Web of Science ®Google Scholar
• Nelson S R, Hawkins P N, Richardson S, Lavender J P, Sethi D, Gower P E, Pugh C W, Winearls C G, Oliver D O, Pepys M B. Imaging of haemodialysis-associated amyloidosis with 1231-serum amyloid P component. Lancet 1991; 338: 335–339
   PubMed Web of Science ®Google Scholar
• Floege J, Burchert W, Brandis A, Gielow P, Nonnast-Daniel B, Hundeshagen H, Shaldon S, Koch K M. Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-P2-microglobulin. Kidney Int 1990; 38: 1169–1176
   PubMedGoogle Scholar
• Gejyo F, Kazama J J, Hasegawa S., Hanma N, Nisht S, Arakawa M, Odano I. 131I-(32-microglobulin scintigraphy in patients with dialysis amyloidosis. Clin Nephrol 1995; 44: S14–S18
   PubMed Web of Science ®Google Scholar
• Hunter W M, Greenwood F C. Preparation of iodine-131 labeled human growth hormone of high specific activity. Nature 1962; 194: 495–496
   PubMed Web of Science ®Google Scholar
• Kazama J J, Takeda T, Katagiri T, Kuwano R, Kumanishi T, Ozawa H, Arakawa M. A histocytochemical study of spot 35-calbindin-D28K in rat kidney. Nephrology 1995; 1: 73–82
   Google Scholar
• Kazama J J, Gejyo F, Ejiri S, Okada M, Ei I, Arakawa M, Ozawa H. Application of confocal laser scanning microscopy to the observation of bone biopsy specimens. Bone 1993; 14: 885–889
   Google Scholar
• Argiles A, Mourad G, Kerr P G, Garcia M, Collins B, Demaille J G. The cells surrounding haemodialysis associated amyloid deposits are mainly macrophages. Nephrol Dial Transp 1994; 9: 662–667
   PubMed Web of Science ®Google Scholar
• Ohashi K, Hara M, Kawai R, Ogura Y, Honda K, Nihei H, Mimura N. Cervical discs are most susceptible to beta2-microglobulin amyloid deposition in the vertebral column. Kidney Int 1992; 41: 1646–1652
   PubMed Web of Science ®Google Scholar
• Niwa T, Miyazaki S, Katsuzaki T, Tatemichi N, Takei Y, Miyazaki T, Morita T, Hirasawa Y. Immunohis-tochemical detection of advanced glycation end products in dialysis-related amyloidosis. Kidney Int 1995; 48: 771–778
   PubMedGoogle Scholar
• Gejyo F, Maruyama H, Teramura T, Kazama J J, Ei I, Arakawa M. Role of macrophages in β2-microglobulin-related dialysis amyloidosis. Contrib Nephrol 1995; 112: 97–104
   PubMedGoogle Scholar
• Floege J, Ehlerding G. Beta-2-microglobulin-asso-ciated amyloidosis. Nephron 1996; 72: 9–26
   PubMedGoogle Scholar
• Rainsbouly R. Location of metastatic breast carcinoma by a monoclonal antibody chelate labeled with indium-111. Lancet 1983; ii: 934–938
   Google Scholar
• Schaeffer J, Floege J, Koch K M. Whole-body scintigraphy. Dialysis Amyloid, C van Ypersele, T B Drueke. FOxford University, New York and London 1996; 145–155
   Google Scholar
• Jadoul M, Noel H, Malghem J, Galant C, van Ypersele C. Histological beta-2-microglobulin amyloidosis 10 years after a successful renal transplantation. Ame J Kid Dis 1996; 27: 888–890
   PubMedGoogle Scholar
• Vincent C, Chanard J, Caudwell V, Lavaud S, Toupance O, Wong T, Revillard J-P. Kinetics of 125I-β2-microglobulin turnover in dialyzed patients. Kidney Int 1992; 42: 1434–1443
   PubMed Web of Science ®Google Scholar
• Chanard J, Vincent C, Caudwell V, Lavaud S, Wong T, Revillard J-P. Beta 2-microglobulin metabolism in uremic patients who are undergoing dialysis. Kidney Int 1993; 43(Suppl 41)S83–S87
   Google Scholar
• Nguyen-Simonnet H, Vincent C, Gauthier C, Revillard J P, Pellet M V. Turnover studies of human β-m in the rat. J Clin Sci 1982; 62: 403–410
   PubMedGoogle Scholar
• Brownlee M. Glycation and diabetic complications. Diabetes 1994; 43: 836–841
   PubMed Web of Science ®Google Scholar
• Niwa T, Katsuzaki T, Momoi T, Miyazaki T, Ogawa H, Saito A, Miyazaki S, Maeda K, Tatemichi N, Takei Y. Modification of β2M with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum. Kidney Int 1996; 49: 861–867
   PubMed Web of Science ®Google Scholar
• Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H. Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alfa and interleukin-1. J Clin Invest 1994; 93: 521–528
   PubMed Web of Science ®Google Scholar
• Linke R P, Hampl H, Lobeck H, Ritz E, Bommer J, Waldherr R, Eulitz M. Lysine-specific cleavage of beta-2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int 1989; 36: 675–681
   PubMed Web of Science ®Google Scholar
• Niwa T, Sato M, Katsuzaki T, Tomoo T, Miyazaki T, Tatemichi N, Takei Y, Kondo T. Amyloid P2-microglobulin is modified with N-(carboxymethyl)lysine in dialysis-related amyloidosis. Kidney Int 1996; 50: 1303–1309
   PubMed Web of Science ®Google Scholar
• Campistol J M, Bernard D, Papastoitsis G, Sole M, Kasirsky J, Skinner M. Polymerization of normal and intact β2-microglobulin as the amyloidogenic protein in dialysis-amyloidosis. Kidney Int 1996; 50: 1262–1267
   PubMed Web of Science ®Google Scholar
• Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T. (32-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 1993; 92: 1243–1252
   PubMed Web of Science ®Google Scholar
• Giardino I, Edelstein D, Brownlee M. Nonenzy-matic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. J Clin Invest 1994; 94: 110–117
   PubMed Web of Science ®Google Scholar